In melanoma NRF2 augments hexose monophosphate shunt (8, 9) and this metabolic adaptation contributes to the intracellular redox balance and allows the BRAFi-resistant melanoma cells to survive under oxidative stress (9). Here, NFE2L2 is linked to melanoma.